Calcium channel blockers for primary and secondary Raynaud's phenomenon
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcium Channel Blockers for Primary and Secondary Raynaud's Phenomenon." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432865/all/Portosystemic_shunts_versus_endoscopic_therapy_for_variceal_rebleeding_in_patients_with_cirrhosis:_Cochrane_systematic_review. Accessed 26 April 2024.
Calcium channel blockers for primary and secondary Raynaud's phenomenon. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432865/all/Portosystemic_shunts_versus_endoscopic_therapy_for_variceal_rebleeding_in_patients_with_cirrhosis:_Cochrane_systematic_review. Accessed April 26, 2024.
Calcium channel blockers for primary and secondary Raynaud's phenomenon. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432865/all/Portosystemic_shunts_versus_endoscopic_therapy_for_variceal_rebleeding_in_patients_with_cirrhosis:_Cochrane_systematic_review
Calcium Channel Blockers for Primary and Secondary Raynaud's Phenomenon [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432865/all/Portosystemic_shunts_versus_endoscopic_therapy_for_variceal_rebleeding_in_patients_with_cirrhosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcium channel blockers for primary and secondary Raynaud's phenomenon
ID - 432865
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432865/all/Portosystemic_shunts_versus_endoscopic_therapy_for_variceal_rebleeding_in_patients_with_cirrhosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -